1 |
Gastrointestinal Tumor Study Group. Prolongation of the disease- free interval in surgically treated rectal carcinoma. N Engl J Med 1985;312:1465-1472
DOI
PUBMED
ScienceOn
|
2 |
Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-715
DOI
PUBMED
ScienceOn
|
3 |
Choi SG, Kim SS, Bae HS. Results of preoperative concurrent chemoradiotherapy for locally advanced rectal cancer. J Korean Soc Ther Radiol Oncol 2007;25:34-42
과학기술학회마을
|
4 |
Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553-559
DOI
ScienceOn
|
5 |
Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002;53:664-674
DOI
ScienceOn
|
6 |
Giratt J, Eraso A, Armengol M, et al. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patient treated with preoperative radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1460-1465
DOI
ScienceOn
|
7 |
Smith FM, Reynolds JV, Kay EW, et al. Cox-2 overexpression in pretreatment biopsies predicts response of rectal cancer to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys 2006;64:466-472
DOI
PUBMED
ScienceOn
|
8 |
Ghadimi BM, Grade M, Difilippaontonio MJ, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinoma to preoperative chemoradiotherapy. J Clin Oncol 2005;23:1826-1838
DOI
ScienceOn
|
9 |
Gerad JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiatiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R004 phase II trial. J Clin Oncol 2003;21:1119-1124
DOI
ScienceOn
|
10 |
Kaminsky-Forett MC, Conroy T, Luporsi E, et al. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer: Int J Radiat Oncol Biol Phys 1998;42:935-941
DOI
ScienceOn
|
11 |
Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Coloretal Dis 1997;12:19-23
DOI
|
12 |
Esposito G, Pucciarelli S, Alaggio R, et al. p27Kip1 is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol 2001;8:311-338
DOI
ScienceOn
|
13 |
John M, Pajak T, Flam M, et al. Dose acceleration in chemoradiation for anal cancer: preliminary results of RTOG 9208. Cancer J Sci Am 1996;2:205-211
PUBMED
|
14 |
Garcia-Aguilar J, Hermandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patient treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304
DOI
ScienceOn
|
15 |
Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum with final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-572
DOI
|
16 |
Francois Y, Nemoz CJ, Baulieux J, et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999;17:2396-2402
DOI
PUBMED
|
17 |
Janjan NA, Khoo VS, Abbrnzzese J, et al. Tumor downstaging and sphincter preservation in locally advanced rectal cancer: the M.D. Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys 1999;44:1007-1038
|
18 |
Gerad JP, Conroy T, Bonnetain F, et al. Preoperatuve radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancer: results of FFCD 9203. J Clin Oncol 2006;24:4620-4625
DOI
ScienceOn
|
19 |
Bouzourene H, Bosmen FT, seelentag W, et al. Importance of tumor regression assessment in predicting the outcome in patient with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94: 1121-1130
DOI
ScienceOn
|
20 |
Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma. Ann Surg Oncol 1996;3:423-430
DOI
|
21 |
Willett CG, Warland G, Hagan MP, et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417-1424
DOI
|
22 |
Moertel C, Childs D, O'Fallon J. Combined 5-FU and radiation therapy as a surgical adjuvant for poor prognostic gastric cancer. J Clin Oncol 1984;2:1249-1254
DOI
PUBMED
|
23 |
Kaminsky-Forrett MC, Conroy T, Luporsi E, et al. Tlevel downstaging and complete pathologic regression after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:815-903
|
24 |
Janjan NA, Abbruzzese J. Pazdau R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 1995;51:153-160
DOI
ScienceOn
|
25 |
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomized trials. Lancet 2001;358:1291-1304
DOI
ScienceOn
|
26 |
Gastrointestinal Tumor Study Group. Radiation therapy and fluorouracial with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 1992;10:549-557
DOI
PUBMED
|
27 |
Bosset JF, Collete L, Calaise G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114-1123
DOI
ScienceOn
|
28 |
Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895-903
DOI
|
29 |
Minsky BD, Cohen AM, Kemney N, et al. Combined modality therapy for rectal cancer; decreased acute toxicity with the preoperative approach. J Clin Oncol 1992;10:1218-1224
DOI
PUBMED
|
30 |
Sanghera P, Wong WY, McConkey CC, Geh JI, Hartley A. Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncology 2008; 20:176-183
DOI
ScienceOn
|
31 |
Boulis-Wassif S, Gerad A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil followed by radical surgery. Trial of the europena orgniazation on resrarch and treatment of cancer gastrointestinal tract cancer cooperative group. Cancer 1984;53:1811-1818
DOI
ScienceOn
|
32 |
Park YA, Sohn SK, Seong J, et al. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol 2006;93:145-150
DOI
ScienceOn
|
33 |
Lowe SW, Bodis S, McClatchy A, et al. p53 status and efficacy of cancer therapy in vivo. Science 1994;266:807-810
DOI
|
34 |
Moore HG, Gittleman AE, Minsky BD, et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 2004;47:279-286
DOI
|
35 |
Vecchio FM, Valentini V, Minsky BD, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752-760
DOI
ScienceOn
|
36 |
Das P, Skibber JM, Rodriguez-Bigas MA, et al. Predictors of tumor response and downstaging in patients who received preoperative chemoradiation for rectal cancer. Cancer 2007;109:1750-1755
DOI
ScienceOn
|
37 |
Losi L, Luppi G, Gavioli M, et al. Prognostic value of Dworak grade of regression (GR) in patient with rectal carcinoma treated properative radiochemotherapy. Int J Colorectal Dis. 2006;21:645-651
DOI
|
38 |
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-987
DOI
ScienceOn
|
39 |
Pucciarelli S, Toppan P, Friso ML, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004;47:1798-1807
DOI
|
40 |
Grann A, Minsky BD, Cohen AM, et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin and concurrent radiation therapy for clinically resectalbe T3 rectal cancer. Dis Colon Rectum 1997;40:515-522
DOI
ScienceOn
|
41 |
Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin-C and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791-799
DOI
PUBMED
ScienceOn
|
42 |
Ahmed NR, Nagle DA, Topham A. Pathologic complete response predicts long-term survival following preoperative radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 1997;39(Suppl):284
|
43 |
Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007;69:1167-1172
DOI
ScienceOn
|
44 |
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740
DOI
ScienceOn
|
45 |
Roodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradio-therapy for rectal cancer. J Clin Oncol 2005;23:8688-8696
DOI
ScienceOn
|
46 |
Mohiuddin M, Regine WF, John WJ, et al. Preoperative chemoradiation in fixed distal rectal cancer: Dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys 2000;46:883-888
DOI
ScienceOn
|
47 |
Rau B, Sturm I, Lage H, et al. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy. J Clin Oncol 2003;21:3391-3401
DOI
ScienceOn
|
48 |
Wheeler JM, Warren BF, Jones AC, Mortensen NJ. Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br J Surg 199;86:1108-1120
DOI
ScienceOn
|
49 |
Lowe SW, Bodis S, MoClateney A, et al. p53 status and efficacy of cancer therapy in vivo. Science 1994;266:807-810
DOI
|
50 |
Brugarolas J, Chandrasekaran C, Gordon JI, et al. Radiationinduced cell cycle arrest compromised by p21 deficiency. Nature 1995;377:552-557
DOI
ScienceOn
|
51 |
Bosset JF, Calais G, Mineur L, et al. Enhanced tumorcidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results-EORTC 22921. J Clin Oncol 2005;23:5620-5627
DOI
ScienceOn
|
52 |
O'Connell MJ, Martenson JA, Wieand HS, et al. Improving adjuvant therapy for rectal cancer by combining protracted- infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 1994;331:502-507
DOI
ScienceOn
|